Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 2,174 shares at $327.18 ($693K) on 2021-09-02, disclosed to the SEC on 2021-09-02.
Seasonal sale ($693k) by CMO, Hematology — this insider has traded BGNE in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $310.53 | 542 | $168K | 24.3% |
| 2 | $310.53 | 542 | $168K | 24.3% |
| 3 | $327.18 | 545 | $178K | 25.7% |
| 4 | $327.18 | 545 | $178K | 25.7% |
| Total | $318.88 avg | 2,174 | $693K | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |